SG
Sagimet Biosciences Inc.
SGMT · NASDAQ
$10.80 -3.10% (-$0.34)
1M +8.62%
Market Cap $351.9M
P/E Ratio -
Div. Yield -
ROE 31.96%
Bulios Fair Price
$8.64
20.0% downside
Current Price
$10.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SGMT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.37x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 20.39%
Asset turnover 0.00x
ROE 31.96%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 45.02x
Int. coverage N/A
Stability
44 /100
Moderate Beta 3.49x
Profitable years 0
EPS volatility 8.80%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SGMT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Happel
Employees
16
Headquarters
San Mateo
Upcoming events
12 NOV
Earnings
Upcoming earnings report